UK markets closed
NIKKEI 225
37,628.48 -831.60 (-2.16%) HANG SENG
17,284.54 +83.27 (+0.48%) CRUDE OIL
83.79 +0.98 (+1.18%) GOLD FUTURES
2,344.20 +5.80 (+0.25%) DOW
38,085.80 -375.12 (-0.98%) Bitcoin GBP
51,734.38 +627.46 (+1.23%)
Novo Nordisk A/S (0QIU.IL)
IOB - IOB Delayed price. Currency in DKK
Add to watchlist
At close: 06:45PM BST
| Previous close | 893.05 |
| Open | 870.80 |
| Bid | 834.00 x 0 |
| Ask | 875.80 x 0 |
| Day's range | 853.30 - 884.00 |
| 52-week range | 86.66 - 932.00 |
| Volume | |
| Avg. volume | 1,004,169 |
| Market cap | 3.605T |
| Beta (5Y monthly) | 0.21 |
| PE ratio (TTM) | 57.78 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 7.08 (1.04%) |
| Ex-dividend date | 18 Aug 2023 |
| 1y target est | N/A |
- Investor's Business Daily
Is Eli Lilly Stock A Buy After Weight-Loss Drug Succeeds In Sleep Apnea Patients?
Lilly is soon planning to ask global regulators to approve tirzepatide for sleep apnea treatment. Is Eli Lilly stock a buy?
- Zacks
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
Eli Lilly, Novo Nordisk, Merck and AbbVie are part of the Zacks Industry Outlook article.
- Zacks
Novo Nordisk (NVO) Stock Sinks As Market Gains: Here's Why
In the latest trading session, Novo Nordisk (NVO) closed at $126.16, marking a -1.93% move from the previous day.
© 2024 Yahoo. All rights reserved.